Roots Analysis (@RootsAnalysis) header
Roots Analysis (@RootsAnalysis) profile picture

Roots Analysis

@RootsAnalysis

Roots Analysis is a global market research, competitive intelligence & strategic consulting firm serving pharma, biotech, medical device and healthcare industry

 Mohali
rootsanalysis.com
Joined May 2013
  • Tweets10.7K
  • Following482
  • Followers791
AI Drug Discovery Has a $1.46 Billion Question AstraZeneca’s insitro deal and Iambic’s IPO reveal the next test for AI: deciding which drug programs deserve the cost of human trials.
AI Drug Discovery Has a $1.46 Billion Question

AI Drug Discovery Has a $1.46 Billion Question

Article · @RootsAnalysis
1
3
207
The future of dentistry is going digital. 🦷 From AI diagnostics to advanced restorative technologies, innovation is reshaping dental care. 📈 2026: $44.71B 🚀 2035: $133.68B 📊 CAGR: 12.94% Explore: rootsanalysis.com/reports/de… #DigitalDentistry #RootsAnalysis
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
4
Pills vs injections isn't the real GLP-1 battle. The bigger question: will oral drugs take market share or bring entirely new patients into treatment? Roots Analysis forecasts a $180B GLP-1 market by 2035. @novonordiskus @EliLillyandCo what wins: efficacy, convenience or access? #GLP1 #Pharma
8
Insights from research report by Roots Analysis on Extractables and Leachables Testing Market by Type of Container / Device Tested (Container / Closures and Packaging Materials, Single Use Systems and Processing Equipment, Medical Devices and Others), Type of Technique Used (Chromatography, Spectroscopy, and Other Techniques), Company Size, Application (Parenteral Drug Products, Inhalation Drug Products, and Oral Solutions and Suspensions) and Geographical Regions – Trends and Forecast 2026-2035
1
1
18
some of the emerging companies in this space include: @Intertek, @Merck_lifesci, @WuXi_AppTec, @EurofinGenomics, @BostonAnalytic, @JordiLabs, @GatewayAnalytic, @ImpactAnalytic, @SelvitaCRO, @RecipharmAB, @Accuprec, @AurigaResearch
1
10
The future of drug safety is becoming more human. Precision Toxicology Market: 2026: $13.8B 2040: $51.8B CAGR: 9.9% AI, organ-on-chip and human-relevant models are reshaping toxicity testing. Explore: rootsanalysis.com/reports/pr… #DrugDiscovery #Toxicology
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
8
AI chips are getting faster. But what about the connections between them? Retimers are becoming critical to high-speed AI infrastructure. 📈 Market: $1.83B (2026) → $4.71B (2035) 11.1% CAGR Explore: rootsanalysis.com/retimer-ma… #Semiconductors #AI #RootsAnalysis
Image from Roots Analysis (@RootsAnalysis)
1
4
🤰🔬 What if software could help transform prenatal screening into smarter, more informed decisions? Prenatal Diagnostic Software is reshaping how healthcare professionals analyze data, support clinical decisions, and navigate pregnancy care. 🧬📊 As technology advances, what’s next for this evolving market? 📈 Explore the insights from Roots Analysis’ Prenatal Diagnostics Report. #PrenatalDiagnostics #HealthTech #MedTech #DigitalHealth #MarketIntelligence
1
12
Could radiopharmaceuticals reshape precision oncology? The global market is projected to grow from $13.1B in 2026 to $38.6B by 2040, at an 8.0% CAGR. The opportunity goes beyond therapeutics—into theranostics, partnerships & isotope supply. #Radiopharmaceuticals #Oncology
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
15
When reading an industry report, what do you check first?
0%Market size & growth
0%Latest industry trends
0%Leading companies
0%Future opportunities
0 votes • Final results
29
The next energy revolution could be hydrogen. The global green hydrogen market is projected to grow from $1.5B (2024) to $125.3B (2035) at a 49.5% CAGR. What's driving the shift? Clean energy, industrial decarbonization and sustainable fuels. 🔗 rootsanalysis.com/green-hydr… #GreenHydrogen #CleanEnergy
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
1
12
What if your next ride arrived from the sky? Flying cars are moving beyond science fiction, and the market opportunity is taking shape. According to Roots Analysis, the Urban Air Mobility Market could reach $206.79B by 2040, growing at a 27.85% CAGR. Would you trust a flying taxi for your daily commute? #RootsAnalysis #FlyingCars #FutureOfMobility
Image from Roots Analysis (@RootsAnalysis)
1
9
Finally, we are heading to the future where there actually are FLYING CARS!! #Flying #vehicles market is going to be a next big thing @Tesla #tesla #innovation #future
1
34
What Will Define the Next Generation of Cancer Therapies? Oncology innovation is accelerating. Which approach has the greatest potential to transform cancer treatment over the next decade?
0%ADCs
0%Bispecific antibodies
0%Cell therapies
0%Cancer vaccines
0 votes • Final results
20
$1.2B potential deal value. Is obesity drug development entering a new era? Zealand Pharma × Generate Biomedicines are betting on AI-engineered, multispecific protein therapies. The bigger question: Can AI-driven discovery translate into better treatments? #Biotech #DrugDiscovery
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
2
38
💉 Injectables hold 93% of GLP-1 market revenue. 💊 But oral therapies are expected to grow faster. With the market projected to hit $180B by 2035, could a pill challenge the pen? 📊 Roots Analysis: rootsanalysis.com/reports/gl… #GLP1 #Biotech
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
24
3 FDA green lights. 3 markets on the move. Roche's Tecentriq. Pfizer's TUKYSA. Teva's WELTRUZA. Beyond the approvals: shifting treatment strategies and new competitive opportunities. Introducing The Roots Intelligence Brief — every Tuesday. #Pharma #Biotech
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
1
32
🧬 $43.56B vs. $16.81B. Two oncology technologies. Two very different approaches. 💉 ADCs: Precision drug delivery. 🔬 Bispecifics: Dual-target engagement. Who shapes the next decade of cancer treatment? Swipe to compare 👉 #ADCs #Oncology #Biotech
🤖 Made with AI
Image from Roots Analysis (@RootsAnalysis)
Image from Roots Analysis (@RootsAnalysis)
1
27
What if AI doesn't just help scientists discover drugs—but starts deciding what to discover next? From AI copilots to autonomous research, pharma R&D could be entering a new era. 📈 $4.7B → $39.8B by 2035. The broader generative AI healthcare market is accelerating. But can AI-led discovery earn scientists' trust? Explore: rootsanalysis.com/reports/ge… #AIinPharma #DrugDiscovery #GenerativeAI #RootsAnalysis
Generative AI in Healthcare Market Size to 2035

Generative AI in Healthcare Market Size to 2035

Generative AI in healthcare market size is set to grow from USD 4.7 billion in 2026 to USD 39.8 billion by 2035 at a 26.7% CAGR.

rootsanalysis.com
1
19
The pharma CMO market is evolving fast. 🚀 What’s driving the next wave of growth, and where are the opportunities? Explore the insights. 💊📊 #PharmaCMO #Pharmaceuticals #MarketInsights #RootsAnalysis
1
1
29
Load more